Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Oxidative stress during leukocyte absorption apheresis

View through CrossRef
AbstractLeukocyte absorption apheresis absorbs leukocytes to the apheresis columns involving leukocyte activation. This process is regarded as bioincompatible and avoided in hemodialysis or other extracorporeal circulation processes. Thus, leukocyte apheresis has a potential risk to exacerbate in vivo oxidative stress. We evaluated the changes in plasma oxidative stress during leukocyte apheresis. Patients diagnosed as ulcerative colitis (UC) and treated with leukocyte apheresis were studied. Adacolumn (celluloseacetate beads) or Cellsorba EX (polyethylenephtarate fiber) was used for the leukocyte absorption device. Oxidative stress was measured by thiobarbituric acid reactive substances (TBARS) and hydroxyl radical (•OH) scavenging activity. Plasma samples were collected from the pre‐ and post‐column sampling port at the start, and from the pre‐column sampling port at the end of the treatment. The •OH signal intensities (OHRI) significantly increased during a column passage, indicating a loss of plasma •OH scavenging activity. However, OHRI was reduced at the end, suggesting a recovery of radical scavenging activity during leukocyte apheresis. Significant decreases of OHRI and TBARS were only observed in the early phase of the therapeutic course. No differences of OHRI and TBARS levels were observed between the two columns. These results indicate that though the plasma antioxidant activity was diminished by a column passage, plasma antioxidant activity recovers during the procedure. This efficient antioxidative effect is limited to the early phase of the therapeutic course. J. Clin. Apheresis 18:61–66, 2003. © 2003 Wiley‐Liss, Inc.
Title: Oxidative stress during leukocyte absorption apheresis
Description:
AbstractLeukocyte absorption apheresis absorbs leukocytes to the apheresis columns involving leukocyte activation.
This process is regarded as bioincompatible and avoided in hemodialysis or other extracorporeal circulation processes.
Thus, leukocyte apheresis has a potential risk to exacerbate in vivo oxidative stress.
We evaluated the changes in plasma oxidative stress during leukocyte apheresis.
Patients diagnosed as ulcerative colitis (UC) and treated with leukocyte apheresis were studied.
Adacolumn (celluloseacetate beads) or Cellsorba EX (polyethylenephtarate fiber) was used for the leukocyte absorption device.
Oxidative stress was measured by thiobarbituric acid reactive substances (TBARS) and hydroxyl radical (•OH) scavenging activity.
Plasma samples were collected from the pre‐ and post‐column sampling port at the start, and from the pre‐column sampling port at the end of the treatment.
The •OH signal intensities (OHRI) significantly increased during a column passage, indicating a loss of plasma •OH scavenging activity.
However, OHRI was reduced at the end, suggesting a recovery of radical scavenging activity during leukocyte apheresis.
Significant decreases of OHRI and TBARS were only observed in the early phase of the therapeutic course.
No differences of OHRI and TBARS levels were observed between the two columns.
These results indicate that though the plasma antioxidant activity was diminished by a column passage, plasma antioxidant activity recovers during the procedure.
This efficient antioxidative effect is limited to the early phase of the therapeutic course.
J.
Clin.
Apheresis 18:61–66, 2003.
© 2003 Wiley‐Liss, Inc.

Related Results

Overview on LDL‐apheresis in cardiovascular diseases
Overview on LDL‐apheresis in cardiovascular diseases
LDL apheresis has been widely accepted as an effective treatment for hypercholesterolemic patients who are resistant to drug and conventional therapy such as in case of familial hy...
Randomized controlled trials in therapeutic apheresis
Randomized controlled trials in therapeutic apheresis
The literature on the use of therapeutic apheresis is often criticized for the preponderance of low to very low quality evidence. Shehata et al. examined the apheresis literature p...
Low‐Density Lipoprotein Apheresis Decreases Ferritin, Transferrin and Vitamin B12, Which May Cause Anemia in Serially Treated Patients
Low‐Density Lipoprotein Apheresis Decreases Ferritin, Transferrin and Vitamin B12, Which May Cause Anemia in Serially Treated Patients
AbstractClinical observations revealed an increased prevalence of iron deficiency anemia without chronic bleeding in patients treated with serial low‐density lipoprotein (LDL) aphe...
Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis
Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis
AbstractThe quality of evidence supporting the use of apheresis in the treatment of individual diseases and disorders is often limited. For most diseases and disorders, randomized ...
Therapeutic apheresis in renal transplantation; current practices
Therapeutic apheresis in renal transplantation; current practices
Apheresis is an important treatment modality for the removal of pathologic antibodies and circulating proteins in kidney transplantation. The use of apheresis has been shown to be ...
Analysis of First Apheresis Services in Ghana-Greater Accra Regional Hospital
Analysis of First Apheresis Services in Ghana-Greater Accra Regional Hospital
Background: At the combined American Society for Apheresis (ASFA) annual meeting/World Apheresis Association (WAA) Congress in 2014, it was observed that there were significant dis...
Lipid apheresis, indications, and principles
Lipid apheresis, indications, and principles
AbstractLow‐density lipoprotein apheresis (LDL apheresis) is a term that describes a group of apheresis techniques and devices that selectively remove apolipoprotein B containing l...

Back to Top